Press Releases

June 15, 2026

BioSpring and Luxna Biotech Extend Strategic XNA Partnership to Include GuNA™ Amidites

Key Highlights:

BioSpring and Luxna extend their existing agreement, enabling BioSpring to manufacture custom next-generation oligonucleotides..

December 2, 2025

Luxna deepens collaboration with BioSpring to Advance Therapeutic Oligonucleotide Development

Osaka, Japan, December 2, 2025. Luxna Biotech Co., Ltd. (President CEO: Hideaki Sato; Headquarters: Suita-shi, Osaka, Japan, hereinafter “Luxna”) and..

November 10, 2025

From Discovery to Commercial Supply: Accelerating the Development of Therapeutic Oligonucleotide Drugs

Frankfurt a.M. / Munich, November 10^th, 2025. BioSpring, a world-leading CDMO for therapeutic oligonucleotide manufacturing and analysis, and..

October 9, 2025

BioSpring Enters Strategic Partnership with Luxna Biotech to Offer Manufacture of Oligonucleotides with Luxna’s advanced XNA Amidites

Frankfurt am Main, Germany. BioSpring, a leading supplier of high-quality therapeutic oligonucleotides, today announced a new collaboration with..

August 28, 2025

The World Visits BioSpring: Consular Corps Tours Frankfurt High-Tech Company

Frankfurt am Main, Germany. Around 70 career and honorary consuls from all over the world visited the Frankfurt-based high-tech company BioSpring as..

July 3, 2025

A New Era Begins: BioSpring Builds High-Tech Manufacturing Facility for Pharmaceutical Nucleic Acid APIs

Offenbach am Main, Germany. Groundbreaking for the future: Together with Hesse’s Minister President Boris Rhein (CDU) and the Mayor of Offenbach, Dr...

May 15, 2025

BioSpring to Participate in TIDES USA 2025 with Workshop and Scientific Presentations

San Diego, CA, USA. With over 1,900 industry experts expected to attend, TIDES USA in San Diego, USA, offers a premier platform for scientific..

January 29, 2025

Hessian State Government Holds Cabinet Meeting at BioSpring

Frankfurt am Main, Germany.The Hessian state government convened today for an external cabinet meeting at BioSpring in Frankfurt am Main. The main..

November 5, 2024

Manufacturer's authorization for cGMP mRNA

Frankfurt am Main, Germany.BioSpring, a global leader in manufacturing and analyzing nucleic acids for therapeutics and diagnostics, is now also..

September 24, 2024

Biotech - Excellence from Hesse: BioSpring's CEO Dr. Sylvia Wojczewski for talks in Brussels

Brussels, Belgium/Frankfurt am Main, Germany. " Biotechnology as a driver of innovation - success factors for a strong location" was the leitmotif of..

August 21, 2024

Hesse's Economics Minister Kaweh Mansoori visits BioSpring

Frankfurt am Main, Germany. Hesse's Economics Minister Kaweh Mansoori (SPD) and the Mayor of Offenbach, Dr. Felix Schwenke (SPD), visited BioSpring..

July 31, 2024

BioSpring and Pantherna agree on strategic cooperation in the field of genome editing

Frankfurt am Main/Hennigsdorf, Germany.BioSpring GmbH and Pantherna Therapeutics GmbH, two leading providers of therapeutic mRNA, have agreed on a..

February 9, 2024

BioSpring Event: Genome Editing – Medicine of the Future

Frankfurt am Main, Germany. BioSpring GmbH, the world's leading manufacturer of genome editing active ingredients, hosted a specialist event on the 9^..